Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ocular perfusion pressure and visual field indice modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration. An acute study on primary open-angle glaucoma patients.
Costagliola C, Parmeggiani F, Ciancaglini M, D'Oronzo E, Mastropasqua L, Sebastiani A. Costagliola C, et al. Among authors: parmeggiani f. Ophthalmologica. 2003 Jan-Feb;217(1):39-44. doi: 10.1159/000068249. Ophthalmologica. 2003. PMID: 12566871 Clinical Trial.
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma.
Costagliola C, Parmeggiani F, Virgili G, Lamberti G, Incorvaia C, Perri P, Campa C, Sebastiani A. Costagliola C, et al. Among authors: parmeggiani f. Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):389-96. doi: 10.1007/s00417-007-0704-4. Epub 2007 Nov 15. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 18004586 Clinical Trial.
Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma.
Sebastiani A, Parmeggiani F, Costagliola C, Ciancaglini M, D'Oronzo E, Mastropasqua L. Sebastiani A, et al. Among authors: parmeggiani f. Acta Ophthalmol Scand Suppl. 2002;236:29-30. doi: 10.1034/j.1600-0420.80.s236.18.x. Acta Ophthalmol Scand Suppl. 2002. PMID: 12390124 Clinical Trial. No abstract available.
Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients.
Costagliola C, Del Prete A, Verolino M, Antinozzi P, Fusco R, Parmeggiani F, Mastropasqua L. Costagliola C, et al. Among authors: parmeggiani f. Graefes Arch Clin Exp Ophthalmol. 2002 May;240(5):379-86. doi: 10.1007/s00417-002-0469-8. Epub 2002 Apr 17. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12073061 Clinical Trial.
169 results